Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy.
<h4>Purpose</h4>To investigate long-term treatment response after intravitreal bevacizumab injections (IVBIs) for central serous chorioretinopathy (CSC).<h4>Methods</h4>This retrospective, interventional study investigated the medical records of 45 eyes of 44 patients with CS...
Main Authors: | Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238725 |
Similar Items
-
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
by: Hae Min Kang, et al.
Published: (2020-01-01) -
Intravitreal bevacizumab for treatment of central serous chorioretinopathy
by: Cihan Ünlü, et al.
Published: (2016-01-01) -
Intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
by: Amr Abdel-Fattah Ali Gab-Alla
Published: (2015-01-01) -
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
by: Subrata Mandal, et al.
Published: (2011-01-01) -
Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
by: Aditya Kelkar, et al.
Published: (2014-07-01)